Sarah E. Hlavinka - Jan 3, 2023 Form 4 Insider Report for Quanterix Corp (QTRX)

Role
Director
Signature
/s/ Brian Keane, as Attorney-in-Fact
Stock symbol
QTRX
Transactions as of
Jan 3, 2023
Transactions value $
$14,995
Form type
4
Date filed
1/4/2023, 03:04 PM
Previous filing
Nov 9, 2022
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTRX Common Stock Award $0 +8.08K +29.23% $0.00 35.7K Jan 3, 2023 Direct F1, F2
transaction QTRX Common Stock Award $15K +1.17K +3.26% $12.86 36.9K Jan 3, 2023 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTRX Stock Option (Right to Buy) Award $0 +12.1K $0.00 12.1K Jan 3, 2023 Common Stock 12.1K $12.86 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest as to 100% of the shares on December 31, 2023 granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
F2 Includes 8,083 restricted stock units.
F3 Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2022.
F4 Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2023.
F5 Represents non-qualified stock option to purchase 12,124 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy.